AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

World Courier and ICS Become First End-to-End Specialty Logistics Provider for Advanced Therapies

January 22, 2020 GMT

VALLEY FORGE, Pa.--(BUSINESS WIRE)--Jan 22, 2020--

AmerisourceBergen has enhanced its logistics offering by integrating two of its businesses, World Courier, a global logistics provider, and ICS, a third party logistics (3PL) provider, creating the first and only specialty logistics partner to deliver complete support from clinical trials through commercialization. The integration offers enhanced global capabilities for manufacturers navigating the complexities of their product’s journey end-to-end, ultimately progressing the global growth of the advanced therapy industry and enabling more patients to be treated with these life-changing products.

“We know the promise that highly specialized treatments, such as cell and gene therapies, bring to the market is enormous. We also recognize that to achieve the best clinical outcomes, therapy innovators must be flanked with the support of a partner with broad expertise, global reach and flawless supply chain execution,” said Sam Herbert, president of World Courier and ICS. “Integrating our expertise enhances our support for partners’ development and commercialization needs and allows us to offer a complete and personalized logistics solution that enables them to stay focused on their core mission of innovation for enhanced patient outcomes.”

Expanding on decades in the clinical trial and commercial 3PL space, World Courier and ICS will create a single partner for manufacturers, with the aim of reducing complexity and improving customer experience while offering a unified world class logistics platform with the highest quality standards.

The integrated organization will also offer a complete cryogenic supply chain. With highly complex and patient-centric structures, cell and gene therapies have challenged the traditional process of specialty products. To manage this complexity for allogeneic products, World Courier and ICS offer vapor-charged cryogenic storage with fully automated technology and temperature-controlled transport from the manufacturer location to a storage facility and then to each point of care in dry shippers, while navigating international borders and maintaining temperature requirements.

By leveraging its existing global quality standards and global footprint, World Courier can charge dry shipments across its network of more than 140 offices, enabling access to cryogenic shipping solutions close to patient and manufacturing locations and create more flexibility and faster response times for patient and hospital needs.

For more information about logistic platforms to support the clinical development and commercialization of therapies, please visit www.worldcourier.com and www.icsconnect.com.

About AmerisourceBergen

AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 22,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $175 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at www.amerisourcebergen.com.

About World Courier

World Courier provides unparalleled specialty logistics services to drive the commercial success of our partners around the globe. For 50 years, we’ve delivered peace of mind through world-class supply chain programs, transportation services, storage of time- and temperature-sensitive products, and innovative, cutting-edge medicines including cell and gene therapies. Through our daily work – and powered by our nearly 3,000 associates – we are united in our responsibility to create healthier futures. With a presence in 50+ countries, World Courier is driven by a commitment to excellence, and provides customized solutions with global reach to increase access to care; making us the most trusted specialty logistics company in the world. Learn more at worldcourier.com.

About ICS

ICS is a leader in innovative distribution services for pharmaceutical manufacturers and an AmerisourceBergen company. As the first pharmaceutical third-party logistics provider with ISO 9001:2015 certification, ICS customizes solutions for pharmaceutical specialty medications, branded and generic pharmaceuticals, biosimilars and innovative therapies such as cell and gene therapies. Integrated business solutions are designed to support pharmaceutical manufacturers regardless of size of the operation and across the commercialization journey. ICS aligns supply chain strategy to pharmaceutical manufacturers’ business goals, delivering tailored healthcare logistics solutions that increase supply chain efficiency, maximize return on investments and enhance patient care. More information at www.ICSConnect.com on LinkedIn or Twitter @ICSConnect.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200122005113/en/

CONTACT: Lauren Esposito, AmerisourceBergen

610-576-3842 – Office

215-460-6981 – Mobile

lesposito@AmerisourceBergen.comDan Alt, Tierney Communications

215-790-4329 – Office

631-879-3615 – Mobile

dalt@tierneyagency.com

KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA

INDUSTRY KEYWORD: OTHER MANUFACTURING HOSPITALS TRANSPORT CLINICAL TRIALS MANUFACTURING PHARMACEUTICAL HEALTH LOGISTICS/SUPPLY CHAIN MANAGEMENT SUPPLY CHAIN MANAGEMENT RETAIL

SOURCE: AmerisourceBergen

Copyright Business Wire 2020.

PUB: 01/22/2020 07:30 AM/DISC: 01/22/2020 07:30 AM

http://www.businesswire.com/news/home/20200122005113/en